Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin

By Sullivan Maria   Vosburg Suzanne   Comer Sandra  

Psychopharmacology, Vol. 189, Iss. 1, 2006-11 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite

A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence

By Johnson Bankole A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1065-1073

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Vivo Release of Naltrexone from Biodegradable Depot Systems

By Liu Yandi   Bruce Sunderland V.   Liu Yandi   George O'Neil A.  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 1, 2006-02 ,pp. : 85-94

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Study of the New Domestic Hypodermic Form of Naltrexone: Prodetoxon Depot Tablets

By Ramenskaya G.   Shikh E.   Arzamastsev A.   Kukes V.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 1, 2005-01 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users

By Webster Lynn R.  

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 259-275

Adis International

Access to resources Recommend Favorite